The abstract is read at the publisher; the summary is JClub's.
A designer saxitoxin-engineered ligand reversibly and selectively inhibits a genetically encoded voltage-gated sodium channel when two outer-mouth mutations are present, with no effect on wild-type channels at working concentrations.
- Why it matters: Subtype-specific sodium channel inhibition is needed to probe NaV isoform physiology without perturbing wild-type NaV activity in neuronal cells or brain tissue.
- What they did: Using small-molecule chemical design plus protein engineering, the study created an orthogonal ligand–channel pair where a modified saxitoxin binds Site 1 on NaV bearing two unique amino acid mutations in the outer pore.
- The result: Introducing the same two replacements into NaV1.1–1.4, 1.6, or 1.7 sensitizes each isoform to the designer STX ligand, enabling acute subtype-selective inhibition for NaV-isoform studies in health and disease.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.